PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 21372496-3 2011 Treatment of tumor necrosis factor-alpha (TNF-alpha) suppressed the cell viability and facilitated the expression of Inter-Cellular Adhesion Molecule 1(ICAM-1) in human glomerular endothelial cells (HGECs) though, pretreatment of NO-NIF significantly recovered the TNF-alpha-induced cell damage to the same extent as Trolox-C did, and suppressed the ICAM-1 expression in a concentration dependent manner. 6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid 317-325 tumor necrosis factor Homo sapiens 13-40 25148872-4 2014 Our results show that the pretreatment with well known antioxidants such as trolox and N-acetyl cysteine (NAC) partially reduced the apoptotic effects due to the administration of TNFalpha plus cycloheximide. 6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid 76-82 tumor necrosis factor Homo sapiens 180-188 24488173-4 2014 The present results also show that the pretreatment with well-known antioxidants such as trolox and N-acetyl cysteine partially reduced the caspase activation caused by the administration of TNFalpha. 6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid 89-95 tumor necrosis factor Homo sapiens 191-199 21372496-3 2011 Treatment of tumor necrosis factor-alpha (TNF-alpha) suppressed the cell viability and facilitated the expression of Inter-Cellular Adhesion Molecule 1(ICAM-1) in human glomerular endothelial cells (HGECs) though, pretreatment of NO-NIF significantly recovered the TNF-alpha-induced cell damage to the same extent as Trolox-C did, and suppressed the ICAM-1 expression in a concentration dependent manner. 6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid 317-325 tumor necrosis factor Homo sapiens 42-51 19289607-7 2009 Treatment of neurons with tumor necrosis factor-alpha (TNF-alpha) stimulated reactive oxygen species generation and resulted in the accumulation of tau-Citrine and tau-Cerulean in neurites, which was inhibited by neutralization of TNF and the free radical inhibitor 6-hydroxy-2,5,7,8-tetramethylchromane-2-carboxylic acid (Trolox). 6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid 266-321 tumor necrosis factor Homo sapiens 26-53 19289607-7 2009 Treatment of neurons with tumor necrosis factor-alpha (TNF-alpha) stimulated reactive oxygen species generation and resulted in the accumulation of tau-Citrine and tau-Cerulean in neurites, which was inhibited by neutralization of TNF and the free radical inhibitor 6-hydroxy-2,5,7,8-tetramethylchromane-2-carboxylic acid (Trolox). 6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid 266-321 tumor necrosis factor Homo sapiens 55-64 19289607-7 2009 Treatment of neurons with tumor necrosis factor-alpha (TNF-alpha) stimulated reactive oxygen species generation and resulted in the accumulation of tau-Citrine and tau-Cerulean in neurites, which was inhibited by neutralization of TNF and the free radical inhibitor 6-hydroxy-2,5,7,8-tetramethylchromane-2-carboxylic acid (Trolox). 6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid 266-321 tumor necrosis factor Homo sapiens 55-58 19289607-7 2009 Treatment of neurons with tumor necrosis factor-alpha (TNF-alpha) stimulated reactive oxygen species generation and resulted in the accumulation of tau-Citrine and tau-Cerulean in neurites, which was inhibited by neutralization of TNF and the free radical inhibitor 6-hydroxy-2,5,7,8-tetramethylchromane-2-carboxylic acid (Trolox). 6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid 323-329 tumor necrosis factor Homo sapiens 26-53 19289607-7 2009 Treatment of neurons with tumor necrosis factor-alpha (TNF-alpha) stimulated reactive oxygen species generation and resulted in the accumulation of tau-Citrine and tau-Cerulean in neurites, which was inhibited by neutralization of TNF and the free radical inhibitor 6-hydroxy-2,5,7,8-tetramethylchromane-2-carboxylic acid (Trolox). 6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid 323-329 tumor necrosis factor Homo sapiens 55-64 19289607-7 2009 Treatment of neurons with tumor necrosis factor-alpha (TNF-alpha) stimulated reactive oxygen species generation and resulted in the accumulation of tau-Citrine and tau-Cerulean in neurites, which was inhibited by neutralization of TNF and the free radical inhibitor 6-hydroxy-2,5,7,8-tetramethylchromane-2-carboxylic acid (Trolox). 6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid 323-329 tumor necrosis factor Homo sapiens 55-58 16910777-7 2006 The lipid hydroperoxide scavengers, beta-hydroxytoluene and trolox, and the iron chelator, desferroxamine, showed partial recovery of TNF-induced apoptosis. 6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid 60-66 tumor necrosis factor Homo sapiens 134-137 14555462-11 2004 In human monocytes, verapamil, Trolox, BAPTA-AM, and W-7 reduced Uf-stimulated TNF-alpha protein release. 6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid 31-37 tumor necrosis factor Homo sapiens 79-88 11298495-5 2001 Scavenging of ROS by means of the antioxidant trolox prevented the TMT-induced release of TNF-alpha from glial cells, while indomethacin was found to suppress ROS formation induced by 1 microM TMT in glial cells. 6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid 46-52 tumor necrosis factor Homo sapiens 90-99